Pharma traded clinical claims for cultural currency at this year’s Super Bowl—but the FDA’s warning to Novo Nordisk shows emotional resonance has limits. Behavioral science is the new frontier in health marketing. #PharmaMarketing #SuperBowl #HealthTech #BehavioralScience #FDA

The psychedelic renaissance is here. 🧠 Our latest feature explores how LSD is being rigorously researched for anxiety & depression. We spoke with Definium's Dr. Dan Karlin about the science, the stigma, and the future of mental health care. #MentalHealth #LSD #PsychedelicScience #DrugDevelopment

Duke's Dr. Amanda Randles explains how #DigitalTwins move medicine beyond static snapshots to dynamic, personalized care. Combining #AI, wearables & supercomputing to predict disease before symptoms appear. #HealthTech#AI#AI #FutureOfMedicine #DigitalHealth

"I didn't leave medicine—I'm just practicing it differently." 🩺 Former GP Dr Bryony Henderson on evolving from frontline care to system-wide impact as Head Medical Director at HeliosX. #HealthcareCareers #ClinicalLeadership #PhysicianBurnout #HealthTech #CareerPivot #MedicalDirector #HeliosX

New data at ECCO 2026: Risankizumab & upadacitinib show sustained remission & real-world impact in UC & Crohn’s. Experts discuss 3-year durability, rapid symptom control & what it means for patients. #News #ECCO26 #IBD #SKYRIZI #RINVOQ #RealWorldEvidence #AbbVie

J.D. Mowery of Bora Pharmaceuticals explains why "friendshoring" is more than a buzzword—it's about patient-centric supply chains, geopolitical resilience, and rethinking manufacturing strategy for 2026 and beyond. #News #Pharma #SupplyChain #Friendshoring #CDMO #Manufacturing #BoraPharmaceuticals

Sensei Biotherapeutics stock skyrockets 206% after acquiring Faeth Therapeutics and securing $200M private placement. The deal advances PIKTOR, a promising PI3K/mTOR inhibitor for endometrial and breast cancer. #News #SenseiBio #Biotech #CancerResearch #StockNews #PIKTOR

Evogene and QUT team up to fight chemotherapy resistance in lung cancer using AI. The collaboration targets cellular pathways to develop new therapies for patients with limited options. #News #Evogene #QUT #AI #CancerResearch #LungCancer #Biotech #DrugDiscovery

Seamflow raises $4.5M to bring AI to the Testing, Inspection and Certification industry. Its platform tackles certification backlogs—cutting medical device approval times from 20+ months. #News #MedTech #AI #HealthTech #VentureCapital #TIC

FDA clears RevealDx's AI-powered lung nodule software to help radiologists assess cancer risk. The tool integrates directly into PACS and is now Medicare reimbursable. #News #HealthTech #AI #FDA #LungCancer #MedicalImaging #Radiology

Immunai CEO Noam Solomon reveals how four new studies—spanning autoimmune disease, cell therapy toxicity, and cancer—are mapping the immune system to unlock safer, personalized treatments. 🧬🔬 #Immunology #AI #Biotech #PrecisionMedicine #CellTherapy #DrugDevelopment

New ICON Biotech survey reveals: China now conducts 25% of global clinical trials. Neurology & cardiology overtaking oncology in R&D focus. Plus insights on funding, AI, and talent. Read the full Q&A. #Biotech #ClinicalTrials #PharmaInnovation #AI

How can AI improve healthcare? By listening. Sciensus uses ambient AI to capture patient insights & give nurses more time for human care. Transforming the patient experience. #FutureOfHealthcare #AIforGood #NurseTech #Microsoft #PatientCentric

The CAR T field is shifting to in vivo platforms that aim to make powerful cell therapies simpler, cheaper, and more accessible. Insights from Vyriad's Luke Russell. #CARTcell #immunotherapy #invivo #biotech #Vyriad #oncology #celltherpay

Cost shouldn’t be your first question in pharma supply chains, says Vector Labs’ Kum Ming Woo. Prioritize quality & availability, diversify geographically, and adopt stage-appropriate strategies. #Interview #Expert #Pharma #SupplyChain #Biotech #Resilience #DrugDevelopment

New study from Rapid Nexus challenges old view of nerve damage. Research shows targeting neuropathy can heal tissue once considered unsalvageable, helping patients avoid amputation. #News #Diabetes #WoundCare #Neuropathy #MedicalInnovation #Research

In 2026, hospitals will split between running their own local AI and forming trusted partnerships, while certified AI medical devices gain major trust, says myTomorrow's Danny den Hamer. #AIinHealthcare #HealthTech2026 #SaMD #LLM #DigitalHealth #Tends

Arkin Capital launches $100M Arkin Bio Ventures III to back transformative biotech companies. The fund takes a hands-on, science-driven approach as an active partner from day one. #News #Interview #Biotech #VentureCapital #Therapeutics #DrugDiscovery

ten23 health & BD partner to enable supply chain readiness for the BD Libertas wearable injector. The full-service solution aims to speed development of large-volume, self-administered therapies. #News #SupplyChain #WearableInjector #Biotech #Pharma #DrugDelivery #Partnership

Genesipre’s gene therapy GENE202 has received Orphan Drug Designation for methylmalonic acidemia (MMA), a rare pediatric disease. #News #GeneTherapy #RareDisease #OrphanDrug #MMA #Biotech

Brainomix's AI imaging tech will serve as a co-primary endpoint in Boehringer Ingelheim's Phase 3 DROP-FPF trial for pulmonary fibrosis—a first for ILD studies. #AI #News #ClinicalTrials #PulmonaryFibrosis #MedicalImaging #Brainomix

VCU researchers awarded $1.8M DoD grant to develop a novel engineered NK cell therapy targeting incurable, advanced prostate cancer (CRPC). #News #ProstateCancer #Immunotherapy #CRPC #CellTherapy #NKcells #IL24 #DoDgrant

Abbott’s $21B acquisition of Exact Sciences signals a new era in cancer detection. We analyze the high-stakes MCED market, pivotal FDA decisions, and the reimbursement battle ahead with Gabelli Funds’ Elena Meng. #MCED #cancerscreening #Abbott #ExactSciences #healthcareinvesting #biotech

FDA approves Stereotaxis MAGiC robotic ablation catheter. A breakthrough for treating complex heart arrhythmias with precise magnetic navigation. #News #Stereotaxis #FDAapproval #cardiology #robotics #arrhythmia #healthtech

Clinical trial start-up delays are rising due to complex protocols & contract bottlenecks. ICON survey data reveals 55% of sites take 5+ months to activate. Solutions require site-centricity & smarter tech. #Interview #ClinicalTrials #StudyStartup #SiteCentricity #ICON #DrugDevelopment

EA Pharma (Eisai) starts Phase III trial in Japan for evenamide, a novel glutamate modulator for schizophrenia. The drug was licensed as part of a €117M deal with Newron Pharmaceuticals. #News #Schizophrenia #ClinicalTrial #MentalHealth #Biotech #Eisai #Evenamide

Canopy secures $22M Series B to expand its connected safety platform for combating workplace violence and modernize hospital operations with location intelligence. #News #HealthTech #SeriesB #WorkplaceSafety #Innovation #LocationIntelligence

New #research by endogene.bio reveals why #endometriosis treatments often fail. The study identifies molecular subgroups & predicts drug response, suggesting non-invasive monitoring via menstrual blood could guide precision therapy. #News #WomensHealth #PrecisionMedicine #ClinicalTrials

Gallop’s LYT-200 shows 13.2-month median survival in late-line AML at #ASH2025—far exceeding historic benchmarks. The anti-galectin-9 antibody combines strong efficacy with a clean safety profile. #News #Leukemia #Oncology #Biotech #ClinicalTrials #AML

Healing chronic wounds twice as fast? SweetBio’s honey-based biomaterial is tackling the hidden amputation crisis, blending ancient remedies with cutting-edge science. #News #WoundCare #Diabetes #MedTech #Innovation #Biomaterials #DiabeticFootUlcer

CNS Pharmaceuticals re-engineers old chemotherapies to cross the blood-brain barrier, targeting aggressive glioblastoma. Dr. Sandra Silberman explains their "back to the future" strategy and two promising drugs. #BrainCancer #Glioblastoma #Biotech #Oncology #BloodBrainBarrier #CNSPharmaceuticals

New data at #ASH2025 show Secure Bio's Copiktra's (duvelisib) consistent efficacy in heavily pretreated PTCL, with strong signal in AITL informing Phase 3 TERZO trial in nTFHL. #news #interview #lymphoma #clinicaltrials #oncology

FoRx Therapeutics raises $50M Series A to advance clinical trial of FORX-428, a PARG inhibitor for PARP-resistant cancers. Initial data expected mid-2026. #News #Biotech #Funding #Oncology #ClinicalTrials #PARG

CTMC’s global alliance partners with Brazil’s Einstein Hospital to democratize cell therapy. CTMC’s Amy Hay details a partnership model to share knowledge and expand cell therapy access worldwide. #News #Interview #CellTherapy #GlobalHealth #MedicalInnovation

FDA approves Cardamyst, the Milestone Pharmaceuticals’ self-administered nasal spray for PSVT. A rapid at-home treatment for sudden rapid heart episodes, available in 2026. #News #PSVT #CARDAMYST #FDAapproval #HeartHealth #MedicalNews

Dr. Margaret Kalmeta, CEO of Rapid Nexus, discusses the first device cleared to treat the tissue around chronic wounds, aiming to prevent amputations. Read more for company's pipeline and future plans #MedTech #WoundCare #FDA #Diabetes #Innovation #Interview #News

New data from Agendia's FLEX study at #SABCS2025 shows genomic signatures like MammaPrint can guide chemo choices & identify benefit in elderly patients. #news #breastcancer #precisionmedicine #realworldevidence

HeartBeam receives FDA clearance for the first cable-free, at-home 12-lead ECG. This breakthrough allows for clinical-grade heart rhythm assessment anytime, anywhere. A major leap for remote cardiac care. #New #HeartBeam #FDA #MedTech #Cardiology #DigitalHealth

AC Immune's Phase 2 vaccine for Parkinson’s shows first-ever signs of potentially slowing disease progression. 100% 100% responder rate for immunogenicity & stabilized biomarkers signal a promising step forward. #News #Parkinsons #Biotech #ClinicalTrial #Neurodegenerative #ACI7104

VUGENE teams up with CRO Inotiv to accelerate AI-driven drug discovery through advanced multi-omics analysis. A key move into the pharmaceutical services market. #News #AI #DrugDiscovery #MultiOmics #Bioinformatics #CRO #Biotech

Sanofi’s #ASH25 data highlight leadership in rare blood diseases, from multi-immune modulation with #BTKinhibitor Wayrilz to long-term hemophilia care with ALTUVIIIO. Transforming patient lives through science. #News #Interview #RareDisease #Hemophilia #Immunoscience

Vyome shares rise on positive Phase 2 data for its wound care gel VT-1953, showing significant reduction in odor & pain. Pivotal study targeted for 2026. #News #Biotech #ClinicalTrial #Healthcare #WoundCare

Tessera Therapeutics' Gene Writing platform hits new preclinical milestones. Data shows edited stem cells exceed curative thresholds for sickle cell disease & successful in vivo generation of functional CAR-T cells. #News #GeneWriting #SickleCellDisease #CAR_T #ASH2025 #Biotech

BREAKING: Dicot Pharma unveils how LIB-01, a new class of ED drug, works. It targets the brain's melanocortin system for a sustained effect, even in non-responders. Phase 2a data shows benefits last 8+ weeks. #News #EDtreatment #menshealth #clinicaltrial #ErectileDysfunction

New data reveals ATIVA's RECELL spray-on skin treatment reduces burn patient hospital stays by 5.6 days, saving ~$42k per case. The minimally invasive approach means less pain, faster healing, and better cosmetic outcomes. #BurnCare #News #MedicalInnovation #PatientOutcomes #HealthcareEfficiency

Iolyx Therapeutics partners with Laboratoires Théa in a deal worth up to $280M to advance ILYX-002, a novel eye drop for autoimmune dry eye. Phase 2 data showed early, sustained improvement. #news #biotech #ophthalmology #dryeye #autoimmune #collaboration

Shocked by the lack of funding in women's health, BioMed X launches XFem Labs with Gates Foundation to bridge the R&D gap. Their first mission: non-hormonal contraception. #News #WomensHealth #HealthEquity #Biotech #GatesFoundation #Innovation

Pharvaris announces positive Phase 3 results for oral deucrictibant in HAE. The drug showed rapid symptom relief in 1.28 hrs & was well-tolerated. Regulatory filings are planned for H1 2026. #News #Pharvaris #deucrictibant #HAE #RareDisease #Phase3 #Biotech

Brainomix's AI imaging (Brainomix 360) doubled endovascular thrombectomy rates & cut transfer delays by 64 mins across 107 NHS hospitals. #News #Study #Stroke #AI #DigitalHealth #Thrombectomy #NHS

New hope against snakebites! 🐍 COVID-era mRNA tech could create a faster, broader treatment to prevent death & disability. A game-changer for rural communities. #mRNA #Snakebite #GlobalHealth #Biotech #MedicalInnovation